Related Experiment Video
Updated: Apr 30, 2026
04:01
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
1.9K
Transoral Robotic Surgery in the HPV Era
Irit Duek1, Salem Billan2, Moran Amit3
1Department of Otolaryngology Head and Neck Surgery, Rambam Health Care Campus, Haifa, Israel;
Rambam Maimonides Medical Journal
|May 9, 2014
Summary
Transoral robotic surgery (TORS) offers a minimally invasive option for oropharyngeal squamous cell carcinoma (OPSCC), demonstrating excellent survival rates and good quality of life. This approach avoids open surgery morbidity for HPV-related cancers.
Area of Science:
- Otolaryngology
- Head and Neck Surgery
- Robotic Surgery
Background:
- Oropharyngeal squamous cell carcinoma (OPSCC) incidence is rising, largely due to human papillomavirus (HPV) infections.
- HPV-positive OPSCC generally has a better prognosis than smoking-related cancers.
- Long-term treatment side effects are a concern for younger, healthier HPV-positive patients.
Purpose of the Study:
- To review current literature on oncologic and functional outcomes of transoral robotic surgery (TORS) for OPSCC.
- To evaluate TORS as an alternative to traditional radiation and chemotherapy or open surgery.
Main Methods:
- Systematic review of existing studies on TORS for OPSCC.
- Analysis of oncologic outcomes (survival, local failure rates).
- Assessment of functional outcomes and quality of life (QOL).
Main Results:
- TORS shows promising oncologic outcomes with a 2-year survival rate exceeding 80% and local failure rates below 3%.
- Patients undergoing TORS report favorable health-related quality of life.
- TORS avoids the significant morbidity associated with open surgical approaches.
Conclusions:
- Transoral robotic surgery (TORS) is an effective treatment for oropharyngeal squamous cell carcinoma (OPSCC).
- It provides excellent oncologic control and functional results with improved quality of life.
- TORS represents a valuable, less invasive alternative for managing OPSCC.
